HRP20080129T3 - Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders - Google Patents
Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disordersInfo
- Publication number
- HRP20080129T3 HRP20080129T3 HR20080129T HRP20080129T HRP20080129T3 HR P20080129 T3 HRP20080129 T3 HR P20080129T3 HR 20080129 T HR20080129 T HR 20080129T HR P20080129 T HRP20080129 T HR P20080129T HR P20080129 T3 HRP20080129 T3 HR P20080129T3
- Authority
- HR
- Croatia
- Prior art keywords
- disorders
- carbon atoms
- halogen
- alkyl
- derivatives
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title 1
- 208000018522 Gastrointestinal disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 150000005625 indol-2-ones Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 150000002367 halogens Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- -1 3,3-disubstituted indol-2-one Chemical class 0.000 abstract 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 abstract 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400955A HU0400955D0 (en) | 2004-05-11 | 2004-05-11 | Pyridine derivatives of dialkyl oxindoles |
HU0500463A HUP0500463A3 (en) | 2005-05-05 | 2005-05-05 | Pyridine derivatives of dialkyl-oxindoles |
PCT/HU2005/000051 WO2005108390A1 (en) | 2004-05-11 | 2005-05-11 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
HRP20080129T3 true HRP20080129T3 (en) | 2008-04-30 |
Family
ID=89985998
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20060403A HRP20060403A2 (en) | 2004-05-11 | 2006-11-20 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
HR20080129T HRP20080129T3 (en) | 2004-05-11 | 2008-03-20 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HR20060403A HRP20060403A2 (en) | 2004-05-11 | 2006-11-20 | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Country Status (21)
Country | Link |
---|---|
US (2) | US20070232662A1 (xx) |
EP (1) | EP1751138B9 (xx) |
JP (1) | JP2007537228A (xx) |
KR (1) | KR20070014189A (xx) |
AT (1) | ATE382045T1 (xx) |
AU (1) | AU2005240844A1 (xx) |
BG (1) | BG109770A (xx) |
CA (1) | CA2566426A1 (xx) |
CZ (1) | CZ2006772A3 (xx) |
DE (1) | DE602005004024T2 (xx) |
EA (1) | EA010865B1 (xx) |
ES (1) | ES2299033T3 (xx) |
HR (2) | HRP20060403A2 (xx) |
IL (1) | IL179030A0 (xx) |
MX (1) | MXPA06013065A (xx) |
NO (1) | NO20065661L (xx) |
PL (2) | PL1751138T3 (xx) |
PT (1) | PT1751138E (xx) |
RS (1) | RS20060622A (xx) |
SK (1) | SK51062006A3 (xx) |
WO (1) | WO2005108390A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ551543A (en) * | 2004-05-11 | 2009-12-24 | Egis Gyogyszergyar Nyrt | Pyridine derivatives of alkyl oxindoles as 5-HT7 receptor active agents |
CZ2006777A3 (cs) | 2004-05-11 | 2007-03-14 | Egis Gyogyszergyár Nyrt. | Nové piperazinové deriváty dialkyloxindolu |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8830312D0 (en) * | 1988-12-28 | 1989-02-22 | Lundbeck & Co As H | Heterocyclic compounds |
US6407112B1 (en) * | 1998-04-22 | 2002-06-18 | Meiji Seika Kaisha, Ltd. | Optically active tetrahydrobenzindole derivative |
FR2779429B1 (fr) * | 1998-06-03 | 2000-07-13 | Synthelabo | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
AR035521A1 (es) * | 2000-12-22 | 2004-06-02 | Lundbeck & Co As H | Derivados de 3-indolina y composicion farmaceutica que los comprende |
-
2005
- 2005-05-11 US US11/596,471 patent/US20070232662A1/en not_active Abandoned
- 2005-05-11 PL PL05745439T patent/PL1751138T3/pl unknown
- 2005-05-11 RS RSP-2006/0622A patent/RS20060622A/sr unknown
- 2005-05-11 AU AU2005240844A patent/AU2005240844A1/en not_active Abandoned
- 2005-05-11 DE DE602005004024T patent/DE602005004024T2/de not_active Expired - Fee Related
- 2005-05-11 CZ CZ20060772A patent/CZ2006772A3/cs unknown
- 2005-05-11 CA CA002566426A patent/CA2566426A1/en not_active Abandoned
- 2005-05-11 EP EP05745439A patent/EP1751138B9/en active Active
- 2005-05-11 KR KR1020067025313A patent/KR20070014189A/ko not_active Application Discontinuation
- 2005-05-11 JP JP2007512358A patent/JP2007537228A/ja active Pending
- 2005-05-11 EA EA200602082A patent/EA010865B1/ru not_active IP Right Cessation
- 2005-05-11 SK SK5106-2006A patent/SK51062006A3/sk not_active Application Discontinuation
- 2005-05-11 ES ES05745439T patent/ES2299033T3/es active Active
- 2005-05-11 PL PL381614A patent/PL381614A1/pl not_active Application Discontinuation
- 2005-05-11 WO PCT/HU2005/000051 patent/WO2005108390A1/en active IP Right Grant
- 2005-05-11 PT PT05745439T patent/PT1751138E/pt unknown
- 2005-05-11 MX MXPA06013065A patent/MXPA06013065A/es active IP Right Grant
- 2005-05-11 AT AT05745439T patent/ATE382045T1/de not_active IP Right Cessation
-
2006
- 2006-11-02 IL IL179030A patent/IL179030A0/en unknown
- 2006-11-20 HR HR20060403A patent/HRP20060403A2/xx not_active Application Discontinuation
- 2006-12-06 NO NO20065661A patent/NO20065661L/no not_active Application Discontinuation
- 2006-12-11 BG BG109770A patent/BG109770A/bg unknown
-
2008
- 2008-03-20 HR HR20080129T patent/HRP20080129T3/xx unknown
-
2009
- 2009-07-09 US US12/500,335 patent/US20090281137A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090281137A1 (en) | 2009-11-12 |
AU2005240844A1 (en) | 2005-11-17 |
DE602005004024T2 (de) | 2008-12-24 |
MXPA06013065A (es) | 2007-05-04 |
EP1751138B1 (en) | 2007-12-26 |
JP2007537228A (ja) | 2007-12-20 |
CZ2006772A3 (cs) | 2007-03-14 |
ATE382045T1 (de) | 2008-01-15 |
EA010865B1 (ru) | 2008-12-30 |
EA200602082A1 (ru) | 2007-04-27 |
NO20065661L (no) | 2007-02-08 |
EP1751138B9 (en) | 2008-11-12 |
ES2299033T3 (es) | 2008-05-16 |
BG109770A (bg) | 2008-05-30 |
HRP20060403A2 (en) | 2007-04-30 |
CA2566426A1 (en) | 2005-11-17 |
EP1751138A1 (en) | 2007-02-14 |
DE602005004024D1 (de) | 2008-02-07 |
US20070232662A1 (en) | 2007-10-04 |
WO2005108390A1 (en) | 2005-11-17 |
KR20070014189A (ko) | 2007-01-31 |
PT1751138E (pt) | 2008-02-25 |
PL1751138T3 (pl) | 2008-05-30 |
IL179030A0 (en) | 2007-03-08 |
SK51062006A3 (sk) | 2007-04-05 |
PL381614A1 (pl) | 2007-06-11 |
RS20060622A (xx) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20040429B1 (en) | Sulphonamide derivatives, the preparation thereof and the application of same as medicaments | |
RS51994B (en) | DERIVATI PIRIDAZINA | |
HRP20171740T1 (hr) | Derivati 5-((halofenil)-3-hidroksi-piridin-2-yl-karboksilne kiseline kao posrednici za pripravu karbonilamino alkanoinskih kiselina, njihovih estera i amida | |
HRP20080477T3 (en) | Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors | |
HUP0203657A2 (hu) | Heterociklusos vegyületek és eljárások a szívgyengeség és más rendellenességek kezelésére | |
RS52562B (en) | (3-ARIL-PIPERAZINE-1-IL) DERIVATI 6,7-DIALCOKSIQUINZOLINE, 6,7-DIALCOKSIFTALAZINE I | |
HRP20080022T3 (en) | Pyrrolopyridine derivatives and their use as crth2 antagonists | |
RS50339B (sr) | Jedinjenja indazola i farmaceutske kompozicije za inhibiranje protein kinaza i postupci za njihovu upotrebu | |
RS54708B1 (en) | ARYLETINYL DERIVATIVES | |
RS50519B (sr) | Supstituisani derivati 8'-piri(mi)dinil-dihidrospiro- /cikloalkilamin/-pirimido/1,2-a/pirimidin-6-ona | |
PE20040512A1 (es) | Compuesto de pirazol-pirimidina anilina | |
EA200970379A1 (ru) | Бициклические гетероароматические соединения | |
ATE556058T1 (de) | 1-(2h)-isochinolonderivat | |
IL161559A0 (en) | Dibenzylamine derivatives and pharmaceutical compositions containing the same | |
DK1074542T3 (da) | Sulfonamidholdige indolforbindelser | |
RS49921B (sr) | Terapeutski biaril derivati | |
RS53903B1 (en) | ETHINYL DERIVATIVES AS POSITIVE MGLUR5 MODULATORS | |
EA200100428A1 (ru) | Производные тетрагидробензазепина, полезные в качестве модуляторов допаминовых d3 рецепторов (антипсихотические агенты) | |
HRP20070498T3 (en) | Indanyl-piperazine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HRP20080119T3 (en) | Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
RS54068B1 (en) | NEW (CONDENSED HETEROCYCLIC PIPERIDINE) DERIVATIVES - (PIPERAZINYL) -1-ALCANONE OR (CONDENSED HETEROCYCLIC PYROLIDINE) - (PIPERAZINYL) -1-ALCANONE AND THEIR USE AS INHIBIT 75 | |
HRP20080129T3 (en) | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders | |
HRP20080097T3 (en) | Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists | |
AR072103A1 (es) | Derivados de (piperazinilo con enlaces puente)-1- alcanona, su utilizacion como inhibidores de p75 y composiciones farmaceuticas que los contienen | |
YU58301A (sh) | 2-aminopiridini koji sadrže supstituente sa kondenzovanim prstenom |